抗3 - 基3 - 甲基利-共酶A的病例 减少酶肌病与晚期宫癌相关
Arnaud Saillant1, Mathilde Rasclard2, Jean-Baptiste Gaume3
1Department of Medical Oncology, Poitiers University Hospital, Poitiers, France; arnaud.saillant@chu-poitiers.fr.
Anticancer research
|September 29, 2023
概括
本案例研究详细介绍了一名70岁的妇女,在宫癌化疗期间被诊断出患有抗-3-基-3-甲基氨酸-辅酶A减少酶肌病. 早期诊断和免疫疗法治疗导致显著改善.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 死性自身免疫性肌肉病症呈现骨肌肉衰弱,通常与癌症有关.
- 由于潜伏的症状而延迟诊断可能导致严重的肌肉缩.
- 这份报告集中在一个患有宫癌和新诊断的肌肉病症的患者身上.
研究的目的:
- 在癌症患者中报告一种抗-3-基-3-甲基酸-辅酶A减少酶肌病症的病例.
- 突出诊断挑战和治疗结果.
- 强调癌症患者早期查肌肉病的重要性.
主要方法:
- 一个70岁的妇女正在接受宫癌化疗的案例报告.
- 评估包括肌酸酸酶水平,抗HMGCR抗体检测,电神经图和肌肉活检.
- 治疗包括静脉注射免疫球蛋白,皮质类固醇和甲醇.
主要成果:
- 患者在化疗期间出现肌肉虚弱和肌痛.
- 诊断证实了死性自身免疫性肌肉病变,肌酸酸酶升高和阳性抗HMGCR抗体.
- 免疫疗法和甲状腺素维持疗法观察到显著改善.
结论:
- 对癌症患者进行罕见肌肉病的查对于癌症患者具有无法解释的肌肉症状至关重要.
- 电神经图谱和MRI帮助早期诊断肌肉病.
- 甲托雷克萨特被证明是有效的作为一个维护疗法对抗HMGCR肌病.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Myasthenia Gravis: Diagnostic Tests
960
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
960
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12

